Papers Presented at Workshops and Symposia

  1. Bubela T & McCabe C. Translational Research for Reimbursement: The Value Engineered Translation Framework. BioCanRx Board Meeting. Toronto, Canada. January 5, 2015. [invited speaker]
  2. Bubela T & McCabe C. Translational Research for Reimbursement: The Value Engineered Translation Framework. Regenerative Medicine Translation – a pathway into clinical practice. London, UK. December 10, 2014. [invited speaker and workshop co-organizer]
  3. Bubela T. Technology Landscaping to Support Value Engineered Translation. Methods to Support Regenerative Medicine Translation. London UK. December 9, 2014. [invited speaker and workshop co-organizer]
  4. Bubela T. Traversing the 3 Rs: Regeneration, Regulation, & Reimbursement. London Regenerative Medicine Network. London, UK. December 8, 2014. [invited keynote speaker]
  5. Bubela T & McCabe C. Addressing Barriers to Clinical Translation of Regenerative Medicine. Driving Regenerative Medicine to the Market and Clinic: An Exploration of Enablers, Impediments and Ethical-Legal Challenges. Toronto, Canada. November 6-7, 2014.
  6. Bubela T.  Legal Agreements and the Governance of the Mouse Research Commons. 2nd Thematic Conference on Knowledge Commons, New York, USA. September 5-6, 2014 [submitted abstract, peer reviewed]
  7. Bubela T. Intellectual Property and the Mouse Commons. The Network for Bodies, Organs and Tissues (NBOT) Inaugural Annual Symposium, 2014. Faculty of Law, University of Sydney, Sydney, Australia. July 14-15, 2014 [invited speaker]
  8. Bubela T. Cost Effective Therapeutic Development of Regenerative Medicine. Leading or Limping?: Regulation in the Age of Personalised Medicine. Centre for Law & Genetics, Faculty of Law, University of Tasmania, Hobart, Australia. July 12-13, 2014 [invited speaker]
  9. Bubela T. Legal, regulatory and systems barriers for clinical translation of innovative bio-therapies for retinopathies. Second International Symposium for Choroideremia Research. Denver, Colorado. June 17-19, 2014 [invited speaker]
  10. Bubela T. Intellectual property issues and the mouse commons. Infrafrontier/IMPC Workshop – Promoting the International Exchange of Mouse Mutant Resources. Munich, Germany, May 8-9, 2014 [invited speaker]
  11. Bubela T. Using patent data to analyse policy issues in translational medicine: regenerative medicine and genomics. Analyzing Policy Impacts on Biotechnology Innovation Using Patent Data. Duke in Washington, Washington D.C., March 14, 2014. [invited speaker and workshop co-organizer]
  12. Bubela T. The effects of the Myriad case on the regenerative medicine industry. The Future of Gene Patents – Making Sense of the Supreme Court’s Decision in the Myriad Case. Rayburn House Office Building, Washington D.C., March 13, 2014. [invited speaker and workshop co-organizer]
  13. Bubela T. International Collaborative Barcoding Research: Moving the Debate Forward on Access and Benefits Sharing of Genetic Resources to Promote Biodiversity. 5th Annual Barcode of Life Conference, Kunming, China, October 7-31, 2013. [invited plenary speaker]
  14. Bubela T. Collaborative Mechanisms for the Clinical Translation of Stem Cell Therapies in a Global Environment. University of Wisconsin Law School, Madison, Wisconsin, October 14, 2013. [invited speaker]
  15. Bubela T,  Gold ER. Commercialization and Intellectual Property 101. Understanding Stem Cell Controversies: An intensive Course on Regulatory and Socio-Ethical Issues. Stem Cell Network, Montreal, Quebec, April 23-25, 2013. [invited speaker, chair and panelist]
  16. Bubela T. Matching Patients, Society and Health System Needs. Understanding Stem Cell Controversies: An Intensive Course on Regulatory and Socio Ethical Issues. Stem Cell Network, Montreal, Quebec, April 23-25, 2013. [invited speaker, chair and panelist]
  17. Bubela T. Commercialization: Stakeholders’ Perspectives. Understanding Stem Cell Controversies: An Intensive Course on Regulatory and Socio-Ethical Issues. Stem Cell Network, Montreal, Quebec, April 23-25, 2013. [invited speaker, chair and panelist]
  18. Bubela T. Commercialization and Translational Challenges for Whole Genome Sequencing. Exploring the unique social/ethical and health system challenges of low cost whole genome sequencing. CIHR Institute of Genetics, Montreal, Quebec, April 19-20, 2013. [invited speaker]
  19. Bubela T. Medicinal Plant Barcoding and Health Products Research – Introduction to Workshop. Medicinal Plant Barcoding and Health Products Research: Moving the Debate Forward on Access and Benefit Sharing. Mexico City, Mexico, February 12-13, 2013. [oral presentation, workshop organizer]
  20. Bubela T. Introduction to International Law on Access and Benefit Sharing: Barcoding and Natural Health Products. Medicinal Plant Barcoding and Health Products Research: Moving the Debate Forward on Access and Benefit Sharing. Mexico City, Mexico, February 23, 2013. [oral presentation, workshop organizer]
  21. Bubela T. How Technology Transfer and Other IP Agreements can Spur Bench to Bedside Translation. Innovative Medicines (IMI) – Critical Path – Collaborating for Cures. February 8, 2013. [invited speaker and panelist]
  22. Bubela T. NorCOMM 2 GE3LS Research, NorCOMM 2 Scientific Advisory Board Meeting, Toronto, Ontario,  January 21, 2013.
  23. Bubela T. Building Robust and Sustainable Bioresources: Lessons from the Mouse World on IP, MTAs and other Thorny Issues. California Institute for Regernative Medicine (CIRM) January 18, 2013 [invited speaker].
  24. Bubela T. Collaborative Mechanisms to Enhance the Clinical Translation of Stem Cell Therapies in a Global Environment. ITRC Meeting, City of Hope, Passadena CA January 17, 2013 [invited speaker by the Canadian Consul General in California].
  25. Bubela T, Li M, Atkins H. Translating Stem Cell Research: Reality and Representations World Stem Cell Summit. West Palm Beach FL December 4-6, 2012 [invited speaker].
  26. Bubela T. UPDATE: Enhancing Translational Stem Cell Research: Innovative Models for Multi-Sectoral Collaboration. Joint Meeting Stem Cell Network Board  and Research Management Committee, Toronto October 26, 2012 [invited speaker].
  27. Bubela T. Strategic uses of Landscaping for Business, Institutions and Policy. Patent Law: Reformed but Un-repented. Life Science INNOVATION Northwest. Seattle, WA July 11-12, 2012 [invited speaker and panelist].
  28. Bubela T. Novel methods for patent landscaping: incorporating statistical modeling. Managing Knowledge in Synthetic Biology: The Creation of Tools for Stronger Intellectual Property Analysis.  Edinburgh, UK, June 20-21, 2012 [co-organiser, speaker, participant].
  29. Bubela T. Translating Stem Cell Research: Reality and Representations. Using and Abusing Evidence in Science and Health Policy. Banff, AB, May 31-June1, 2012 [invited speaker].
  30. Bubela T. New Approaches to health law teaching and research. Curriculum Network Meeting: The Expanding Health Law Curriculum: New Questions, New Approaches, New Scholarship. University of Toronto, ON, May 3, 2012 [invited speaker].
  31. Bubela T. Li MD, Bieber M, Atkins H, Translating Stem Cell Research: Reality and Representations. Till & McCullough Meetings, Montreal QC, April 30-May 2, 2012 [invited plenary speaker].
  32. Bubela T. Enhancing Translational Stem Cell Research: Innovative Models for Multi-Sectoral Collaboration. Joint Meeting Stem Cell Network  Board  and Research Management Committee, Toronto March 7, 2012 [invited speaker].
  33. Bubela T. Sustaining Equitable Research Partnerships: An Institutional Perspective. Annual Meeting on Drugs that Target Multiple Receptors for Anthelmintics, University of Botswana, Gabarone Botswana, March 1-2, 2012 [invited speaker].
  34. Bubela T, Jardine C, Driedger SJ. Building equitable research partnerships for HIV vaccine research. University of Nairobi Collaborative Meeting, University of Nairobi, Kenya, 23-27 January 2012 [ unable to attend in person, presentation given by SJ Driedger].
  35. Bubela T. Clinical translation of stem cell research: Addressing the challenges. Workshop on the Innovation Pool in Australian Biotechnology: Assessing Strategies for Fostering Innovation through Patenting and Patent Pooling, University of Tasmania, Hobart, Australia 15-16 December 2011 [invited speaker and workshop participant].
  36. Bubela T. NorCOMM 2: GE3LS Research. NorCOMM 2 Scientific Advisory Board Meeting. Toronto, 15 December 2011 [invited speaker – presentation delivered via Skype].
  37. Bubela T. Synthetic biology and production of opiates: Overview of social, ethical & legal issues. Tasmanian Alkoloids, Launceston, Australia, 12 December 2011 [presentation and discussion].
  38. Bubela T. Access to genetic resources and benefit sharing: Implications for barcoding. 4th International Barcode of Life Conference. University of Adelaide, Adelaide, Australia, 28 November – 3 December 2011 [contributed oral presentation].
  39. Bubela T.  Clinical translation of stem cell research: Addressing the challenges. Innovation 2011, Montreal, 20-21 November 2011 [invited speaker and panelist].
  40. Bubela T. Managing IPRs in In Genomic Diagnostics: Lessons from the Mouse World. Workshop on Intellectual Property and Genomic Diagnostics. Duke University 4 November 2011 [invited speaker and workshop participant].
  41. Bubela T. Managing the pre-competitive research environment: Evidence and Outcomes.  6th Annual Conference of the EPIP Association: Fine-Tuning IPR Debates. Université libre de Bruxelles, Brussels, Belgium, September 8-9, 2011 [invited keynote speaker and panellist].
  42. Bubela T. Science’s “Unobtanium”? – Building Robust Research Commons. VALGEN Workshop Intellectual Property in the ABC World, Banff 21 January 2011 [invited speaker].
  43. Bubela T. Building a Robust Research Commons: Enhancing the Precompetitive Environment. 2010 ITMAT International Symposium Interesting Times: The Academic Contribution to Development of novel Therapeutics in an Era of Reform, University of Pennsylvania School of Medicine, 26-27 October 2010 [invited speaker].
  44. Bubela T. Models for Constructing a Robust Research Commons. Creative Commons, San Francisco, 8 September 2010 [invited speaker].
  45. Bubela T. Managing Intellectual Property within a Precompetitive Space. QB3 University of California, San Francisco, 7 September 2010 [invited speaker].
  46. Bubela T. Building a Robust Research Commons: Enhancing the precompetitive environment. Banff Conference on Plant Metabolism, 24-28 June 2010 [invited speaker].
  47. Bubela T. Setting the Scene – Models for Dealing with IP. Session on Intellectual Property within a Precompetitive Space. Precompetitive Boundaries: Open Innovation in Drug Discovery and Development  Meeting, The Wellcome Trust, London June 17-18, 2010 [invited speaker].
  48. Bubela T. Intellectual Property and the “Mouse Commons”. Mouse Models for Human Disease, CASIMIR Consortium and the European Commission, the Royal Society, London, May 19-20, 2010 [invited speaker].
  49. Bubela T. Socially Responsible Management of Health Research. 2010 ICRH Young Investigators (YI) Forum, Vancouver, May 7, 2010.
  50. Bubela T. The Case for Socially Responsible Licensing in Alberta. Licensing Executives Society Edmonton Chapter, Faculty Club, University of Alberta, April 14, 2010[invited speaker].
  51. Bubela T. Exploring the bounds of the public domain: Who wins; who loses (A Contrarian Rant), UN-IP Workshop, European University Institute, Florence, Italy, March, 2010 [invited speaker].
  52. Bubela T. Intellectual Property and Commercialization Models, PhytoMetaSyn Scientific Advisory Board Meeting Montreal, Quebec, March 19-20, 2010.
  53. Bubela T.The Stem Cell Research Environment: Drawing the Evidence and Experience Together, Stanford University, California, January 22, 2010 [invited speaker].
  54. Bubela T, Morin JF. Lost in Translation: The Canadian Access to Medicines Regime from Transnational Activism to Domestic Implementation. Insights: A Focus on Public Health Research, School of Public Health, University of Alberta, November 12, 2009.
  55. Bubela T, Spear M. Health Communication 2.0: Hype or Reality. Public Health Seminar of Public Health, University of Alberta, October20, 2009 [invited speaker].
  56. Bubela T. Grand Challenges for Evidence and Health Policy: Metrics and Indicators in Complex Systems. National Health Law Conference, Montreal, October 2-3, 2009 [invited speaker].
  57. Bubela T. Aligning Metrics with Mission for Biomedical Research. Faculty of Law, University of Cape Town, Cape Town, May 12, 2009 [invited speaker].
  58. Bubela T, Einsiedel E. GE3LS and Socio-Economic Research: NorCOMM. NorCOMM AGM, Banff, April 24, 2009.
  59. Bubela T, Gold R. (2009) Toward a New Era in Intellectual Property: Implications and Opportunities for CIPO, Canadian Intellectual Property Office, Ottawa, February 18, 2009 [invited speaker].
  60. Bubela T. Aligning Mission with Metrics for Publicly Funded Research Institutions: The case of the Canadian Stem Cell Network. The UN-IP Workshop, Floating the Knowledge Management Boat in a Sea of Intellectual Property Rights 10 December 2008, SCRIPT/AHRC Centre, Edinburgh University, Edinburgh [invited speaker].
  61. Bubela T. Toward a New Era for Intellectual Property: Research Methods. Responsible Innovation, 8-9 December 2008, Wageningen University and Research Centre, Wageningen, Netherlands [invited speaker].
  62. Bubela T, Gold R. Toward a New Era for Intellectual Property: From Confrontation to Negotiation. Global Forum for Health Research Ministerial, Special Session on Intellectual Property Regimes, 15 November-19 November 2008, Bamako, Mali.
  63. Bubela T, Beas Rodriguez E, Metcalf C, Nnadozie K, Rodriguez E, Carbone J. “Respecting, Promoting, and Protecting Traditional Knowledge: A Comparative Case Study of Brazil, Kenya and Northern Canada.”Propriété intellectuelle, biotechnologies, et enjeux sociaux à l’heure de la globilisation, Science Po, Paris, 13-14 November 2008 [invited speaker].
  64. Bubela T. “Aligning Mission and Metrics for Biomedical Research”. School of Public Health, University of Alberta, September 30, 2008.
  65. Bubela T, Caulfield T. “Industry perspectives: Genetic Research, CAM and Pharma Clinical Trials, and Conflicts of Interest.”From Evidence to Policy: Popular Representations and Science Communication Workshop, Washington D.C. Jun 9-10, 2008 [invited speaker].
  66. Ogbogu U, Bubela T, Caulfield T. “The stem cell revolution: Claims, expectations and reactions in political, media and public discourse.” From Evidence to Policy: Popular Representations and Science Communication Workshop, Washington D.C. Jun 9-10, 2008.
  67. Bubela T,Einsiedel E. “GE3LS and Socio-Economic Research: NorCOMM” NorCOMMAGM, Toronto, May 14, 2008.
  68. Bubela T, Caulfield T, Shelley J. “Public Representations of NutrigenomicTesting : Website Content and Media Coverage”Nutrigenomics 08, Melbourne Australia May 5-9, 2008 [invited speaker].
  69. Morin JF, Bubela T, Wry T. “Lost in Translation: NGOs and Patent Governance” 2008 International Studies Association Conference, San Francisco, USA, March 22-29, 2008.
  70. Caulfield T, Bubela T, et al., “Nutrigenomics and the Promise of Prevention: Representations and Realities” Visions, National Health Law Conference, Banff, Alberta, November 8-10, 2007.
  71. Bubela T. “Managing Large Collaborative Research Project IP and Research Outputs for Innovation and Access: NorCOMM, IPY”, National Graduate Institute for Policy Studies, Tokyo, Japan, October 26, 2007 [invited speaker].
  72. Bubela T, E Einsiedel and C Ashley. “North American Conditional Mouse Mutagenesis Project: GE3LS and Socio-Economic Research”, Ontario Genomics Institute GE3LS Workshop, Toronto September 4, 2007.
  73. Ogbogu U, Bubela T, and Fernando K. Paranoia: The Media’s Role in Shaping Public Confidence in Biotechnology Regulation. 30th International Academy of Law and Mental Health International Congress, Padua, Italy June 25-30, 2007.
  74.  Caulfield T, Alfonso V, Shelly J and Bubela T. “Nutrigenomics and the Promise of Prevention: Representations and Realities”  Media, marketing, regulation and nutrigenomics: An International Workshop, Exeter, England, June 22-23, 2007.
  75. Bubela T. Canadian Perspectives on Traditional Knowledge. Unpacking Access:  Towards the Practical Implementation of Biotechnology European University Institute, Florence, Italy June 4-5, 2007[invited speaker].
  76. Bubela T and Einsiedel E. GE3LS and Socio-Economic Research: NorCOMM AGM, Toronto, May 24-25, 2007.
  77. Bubela T and Strotmann A. “IP Structures and Knowledge Flows in Genomics: Developing Better Measures.” Genomics and Intellectual Property: Considering Alternatives to Traditional Patenting Workshop hosted by Genome BC and The W. Maurice Young Centre for Applied Ethics, Vancouver, March 9, 2007[invited speaker].
  78. T. Caulfield, T. Bubela and C.E. Murdoch. “Myriad in the Media:
    An Analysis of Newspaper Reports.” Genomics and Intellectual Property: Considering Alternatives to Traditional Patenting Workshop hosted by Genome BC and The W. Maurice Young Centre for Applied Ethics, Vancouver, March 9, 2007[invited speaker].
  79. T. Bubela and E. Einsiedel. “Activity 24: GE3LS & Socio-economic Research”, NorCOMM Quarterly Meeting, Mt. Sinai Hospital, Toronto, March 4, 2007.
  80. E.R. Gold and T. Bubela. “Of Mice and Women” Genomics Institute, Duke University, December 5, 2006[invited speaker].
  81. Hicks G, Bubela T, Ding H, Einsiedel EF, Jefferies W, Lefevbre L, McKerlie C, Nagy A, Stanford WL, Rancourt D, Ding and Rossant J. Pre-Clinical Mouse Models for Arthritis. Canadian Arthritis Network Annual Scientific Conference, Winnipeg, December 2006.
  82. Hicks G, Bubela T, Ding H, Einsiedel EF, Jefferies W, Lefevbre L, McKerlie C, Nagy A, Stanford WL, Rancourt D, Ding and Rossant J.  NorCOMM: High Throughput Mammalian Functional Analysis for the Discovery of Novel Determinants of Human Disease. World Congress of Psychiatric Genetics, Cagliari Italy, October 2006.
  83. T. Bubela. “Canadian Science and Technology Policy” Intellectual Property Modelling Group, Centre for Intellectual Property Policy, McGill University.  Intellectual Property, Biotechnology Capacity and Development Buenos Aires, Argentina, September 25-26, 2006.
  84. T. Bubela, E. Einsiedel. “Testing New Governance Models for Genomic Innovation: GE3LS Research and NorCOMM” NORCOMM Workshop and Team Research Meeting, Toronto, 14 June 2006.
  85. T. Bubela, M. Koper, H. Boon, and T.Caulfield. “Media Portrayal of Herbal Remedy Versus Pharmaceutical Clinical Trials: Impacts on Decision-Makers.” World Association for Medical Law 16th World Congress on Medical Law, Toulouse, France 7-11 August 2006.*
  86. T. Bubela and T Caulfield. “Commercialisation and Converging Social Concerns – a need for new governance?” Human Genetics Licensing Symposium, Health Canada and Genome BC, Vancouver, March 20, 2006.
  87. T. Caulfield and T. Bubela. “”Stem Cell Patents: Converging Social Concerns?” Patenting Lives, Queen Mary Intellectual Property Research Institute, London, U.K., December 1-2, 2005 [invited speaker].
  88. T. Bubela, S. DeBow and T. Caulfield. “Stem Cells, Politics and the Progress Paradigm” Stem Cell Network Annual General meeting, Calgary, November 23-25, 2005.
  89. T.Caulfield, T. Bubela, V. Kurata, U. Ogbogu. “Unpacking the Justifications for the Canadian Ban on Therapeutic Cloning” Challenges in Regenerative Medicine (ChaRM) Conference, Toronto, October 20-21, 2005.
  90. T. Bubela, T. Caulfield, M. Koper and T. Moran. “Media Portrayal of Herbal Remedy Clinical Trials” Functional Foods, Nutraceuticals& Natural Health Products: From Research and Innovation to Policy and Regulation, AFMNet, Montreal, October 3-4, 2005.
  91. T. Bubela. “What’s Hot in Canadian IP Law” Biotechnology and Intellectual Property: Reinventing the Commons, Montreal, Canada, September 25-27, 2005.
  92. T. Bubela, T. Caulfield and V. Kurata. “Parliament, Politics and Science Policy: Case Study of Stem Cells & SCNT” Bioethics and Governments: Comparing French and American Responses to New Human Technologies Stanford Law School, Stanford University, September 22-24, 2005 [invited speaker].
  93. T. Caulfield and T. Bubela. “Stem Cell: Politics, Publics and the Press” Looking Back, Looking Forward: Lessons for Governing Emerging Technologies, Canadian Biotechnology Secretariat and Genome Canada, Ottawa, September 22, 2005.
  94. T. Caulfield and T. Bubela. “Parliamentary Politics and Science Policy: The Case of Stem Cell Research,” Sheffield Institute of Biotechnology Law and Ethics, University of Sheffield, England, September 14, 2005.
  95. C. Metcalf and T. Bubela. “Traditional Ecological Knowledge, Indigenous Rights and the ConstitutionLaw and Society Summer Institute, Oxford University, UK, June 2005.
  96. L.M. Cloutier and T.M. Bubela. “The Management of Technology at the Source: An Institutional Economics Analysis of the Commercialization of Intellectual Property by Universities” Science for Sale? Public Communication of Science in a Corporate World, Cornell University, Ithaca, NY, 15-17 April 2005.
  97. T. Caulfield and T. Bubela. “Media, Marketing and Genetic Research: The Policy Implications of ‘Genohype,'” American Society of Human Genetics Annual Meeting, Toronto, October 27, 2004.
  98. T. Caulfield and T. Bubela. “Media Portrayals of Genetic Discoveries: What Does the Evidence Tell Us?” HGM2004, Human Genome Meeting, HUGO, Berlin, Germany, April 4-7, 2004.
  99. Bubela, T.M. and Caulfield, T. “Media Portrayal of Genetic Discoveries: A Comparison of Newspaper Stories and Peer Reviewed Research Papers.” (2003) Paper presented at the “GE3LS Winter Symposium” Montreal, Quebec.
  100. Caulfield, T. and Bubela, T. “Headlines and hype?; Media portrayals of genetic discoveries.” (2003) Paper presented at “Crossing Over: Genomics in the Public Arena” Genome Prairie, Kananaskis, Alberta.
  101. Caulfield T, Bubela T. Media Portrayal of Genetic Discoveries: A Comparison of Newspaper Stories and Peer Reviewed Publications (with Tania Bubela) (abstract #1266), The American Society of Human Genetics, Baltimore, October 15-19, 2002.